VRS
Virginia Retirement Systems’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7M | Sell |
85,123
-334,500
| -80% | -$42M | 0.07% | 224 |
|
|
2025
Q1 | $46.4M | Buy |
+419,623
| New | +$46.4M | 0.34% | 81 |
|
|
2023
Q3 | $67.6M | Buy |
600,823
+456,800
| +317% | +$51.4M | 0.67% | 31 |
|
|
2023
Q2 | $13.6M | Sell |
144,023
-36,300
| -20% | -$3.42M | 0.13% | 177 |
|
|
2023
Q1 | $18.3M | Buy |
180,323
+3,523
| +2% | +$357K | 0.19% | 151 |
|
|
2022
Q4 | $21.1M | Sell |
176,800
-6,200
| -3% | -$741K | 0.22% | 118 |
|
|
2022
Q3 | $19.4M | Buy |
+183,000
| New | +$19.4M | 0.22% | 121 |
|
|
2021
Q2 | – | Sell |
-2,700
| Closed | -$263K | – | 1104 |
|
|
2021
Q1 | $263K | Buy |
+2,700
| New | +$263K | ﹤0.01% | 1023 |
|
|
2020
Q3 | – | Sell |
-14,700
| Closed | -$1.79M | – | 1144 |
|
|
2020
Q2 | $1.79M | Buy |
14,700
+8,900
| +153% | +$1.09M | 0.02% | 402 |
|
|
2020
Q1 | $502K | Sell |
5,800
-20,100
| -78% | -$1.74M | 0.01% | 793 |
|
|
2019
Q4 | $2.78M | Buy |
25,900
+8,900
| +52% | +$957K | 0.03% | 382 |
|
|
2019
Q3 | $1.53M | Buy |
17,000
+200
| +1% | +$18K | 0.02% | 517 |
|
|
2019
Q2 | $1.42M | Buy |
16,800
+7,900
| +89% | +$667K | 0.02% | 547 |
|
|
2019
Q1 | $784K | Buy |
8,900
+2,700
| +44% | +$238K | 0.01% | 752 |
|
|
2018
Q4 | $443K | Hold |
6,200
| – | – | 0.01% | 908 |
|
|
2018
Q3 | $762K | Hold |
6,200
| – | – | 0.01% | 795 |
|
|
2018
Q2 | $609K | Buy |
+6,200
| New | +$609K | 0.01% | 845 |
|